Early low-density lipoprotein apheresis for steroid-resistant minimal change disease with acute kidney injury: a case report.

IF 0.7 Q4 UROLOGY & NEPHROLOGY
CEN Case Reports Pub Date : 2025-10-01 Epub Date: 2025-06-30 DOI:10.1007/s13730-025-01016-y
Miya Hiramatsu, Masatoshi Inoue, Naoki Kamegai, Ohno Michiya, Junichiro Yamamoto
{"title":"Early low-density lipoprotein apheresis for steroid-resistant minimal change disease with acute kidney injury: a case report.","authors":"Miya Hiramatsu, Masatoshi Inoue, Naoki Kamegai, Ohno Michiya, Junichiro Yamamoto","doi":"10.1007/s13730-025-01016-y","DOIUrl":null,"url":null,"abstract":"<p><p>We report the case of a 75-year-old woman with steroid-resistant minimal change disease (MCD) whose refractory proteinuria and hypoproteinemia were controlled with early low-density lipoprotein apheresis (LDL-A). She was initially treated with steroid therapy, including methylprednisolone pulse. However, her hypoproteinemia, severe proteinuria, accompanied with renal insufficiency persisted despite these therapies. We initiated hemodialysis on day 17, and LDL-A on day 18. After the treatment, we found an improvement in her urine protein excretion, hyperlipidemia, and hypoproteinemia gradually. Her renal function returned to normal. We added cyclosporine A (CyA) after confirming the normal renal function. Her proteinuria was 0.693 g/day on day 350 and she achieved incomplete remission type I. There are few reports of the efficacy of LDL-A in older patients with MCD with acute kidney injury (AKI). In addition, there are only a few reports of cases in which LDL-A was introduced early, as in this case. This case suggests that early LDL-A may be an effective therapy for steroid-resistant MCD with AKI.</p>","PeriodicalId":9697,"journal":{"name":"CEN Case Reports","volume":" ","pages":"751-756"},"PeriodicalIF":0.7000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457249/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CEN Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13730-025-01016-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

We report the case of a 75-year-old woman with steroid-resistant minimal change disease (MCD) whose refractory proteinuria and hypoproteinemia were controlled with early low-density lipoprotein apheresis (LDL-A). She was initially treated with steroid therapy, including methylprednisolone pulse. However, her hypoproteinemia, severe proteinuria, accompanied with renal insufficiency persisted despite these therapies. We initiated hemodialysis on day 17, and LDL-A on day 18. After the treatment, we found an improvement in her urine protein excretion, hyperlipidemia, and hypoproteinemia gradually. Her renal function returned to normal. We added cyclosporine A (CyA) after confirming the normal renal function. Her proteinuria was 0.693 g/day on day 350 and she achieved incomplete remission type I. There are few reports of the efficacy of LDL-A in older patients with MCD with acute kidney injury (AKI). In addition, there are only a few reports of cases in which LDL-A was introduced early, as in this case. This case suggests that early LDL-A may be an effective therapy for steroid-resistant MCD with AKI.

早期低密度脂蛋白单采治疗类固醇抵抗性微小改变疾病伴急性肾损伤1例报告
我们报告一例75岁的女性患有类固醇抵抗性微小改变病(MCD),其难治性蛋白尿和低蛋白血症通过早期低密度脂蛋白单采(LDL-A)控制。她最初接受类固醇治疗,包括甲基强的松龙脉冲。然而,尽管这些治疗,她的低蛋白血症,严重蛋白尿,并伴有肾功能不全持续存在。第17天开始血液透析,第18天开始LDL-A检测。治疗后,患者尿蛋白排泄、高脂血症、低蛋白血症逐渐改善。她的肾功能恢复正常。确认肾功能正常后给予环孢素A (CyA)治疗。在第350天,她的蛋白尿为0.693 g/天,她达到i型不完全缓解。很少有报道LDL-A对老年MCD合并急性肾损伤(AKI)患者的疗效。此外,只有少数报告的情况下,LDL-A引入早期,如本例。本病例提示早期LDL-A可能是治疗类固醇抵抗性MCD合并AKI的有效方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CEN Case Reports
CEN Case Reports UROLOGY & NEPHROLOGY-
CiteScore
1.90
自引率
0.00%
发文量
80
期刊介绍: Clinical and Experimental Nephrology (CEN) Case Reports is a peer-reviewed online-only journal, officially published biannually by the Japanese Society of Nephrology (JSN).  The journal publishes original case reports in nephrology and related areas.  The purpose of CEN Case Reports is to provide clinicians and researchers with a forum in which to disseminate their personal experience to a wide readership and to review interesting cases encountered by colleagues all over the world, from whom contributions are welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信